Cargando…
Implementation of high‐throughput non‐invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross‐sectional survey of maternity units and expert interviews
BACKGROUND: Previously, routine antenatal anti‐D prophylaxis (RAADP) was administered to all RhD‐negative mothers to reduce the risk of sensitisation in the UK's National Health Service (NHS). If the baby is RhD‐negative, RAADP is not required. In 2016, the UK National Institute for Health and...
Autores principales: | Ryczek, Edyta, White, Judith, Carolan‐Rees, Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496714/ https://www.ncbi.nlm.nih.gov/pubmed/32447792 http://dx.doi.org/10.1111/tme.12702 |
Ejemplares similares
-
A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales
por: Szczepura, Ala, et al.
Publicado: (2011) -
Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD
por: Clausen, Frederik Banch, et al.
Publicado: (2013) -
High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis
por: Yang, Huiqin, et al.
Publicado: (2019) -
Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status
por: Legler, Tobias J., et al.
Publicado: (2021) -
Normothermic Insufflation to Prevent Perioperative Hypothermia and Improve Quality of Recovery in Elective Colectomy Patients: Protocol for a Randomized Controlled Trial
por: Ryczek, Edyta, et al.
Publicado: (2019)